Dynamic Bio, a public-private collaboration platform for the biopharmaceutical sector jointly built by the Ministry of Food and Drug Safety (MFDS), industry and academia, has marked its 15th anniversary. The MFDS held a commemorative event on May 27 at the Atlas Hall of The Westin Josun Seoul Parnas in Gangnam-gu, Seoul, co-hosted with the Korea Biopharmaceutical Association under the theme "15 Years Built Together, Envisioning the Future of K-Bio Together."
Dynamic Bio is a public-private consultative body designed to develop policies and identify regulatory improvement tasks related to biopharmaceutical industry support. It is organized into nine subcommittees — biopharmaceutical policy development and stable supply, advanced bio policy development, biological products, recombinant DNA products, advanced biopharmaceuticals, next-generation therapeutics, Good Manufacturing Practice (GMP), export support, and biosimilars — with a total of 583 members. The platform has been credited with driving K-Bio achievements through joint government-industry discussions on regulations and guidelines.
MFDS Commissioner Oh Yu-kyoung said in a congratulatory address, "We will continue to support K-Bio through Dynamic Bio so that the voice of industry and policy remain connected, enabling K-Bio to build world-class competitiveness in safety and quality and advance beyond Korea onto the global stage." She added, "Dynamic Bio has played a major role in the research, development, approval and export of biopharmaceuticals over the past 15 years."
The MFDS explained that by reflecting outcomes discussed at Dynamic Bio, it has achieved a total of 101 regulatory improvements in the biopharmaceutical sector, including enactments and revisions of laws, public notices and guidelines. "As a result of communication with industry, outcomes such as the special act on regulatory support for contract development and manufacturing organizations (CDMOs) and a draft guideline on streamlining Phase 3 clinical trials for biosimilars were made possible," Commissioner Oh said.
